Pacific Biosciences Of California (PACB) Price to Book (2010 - 2026)

Pacific Biosciences Of California has reported Price to Book for 17 years, with the latest figure at 15.72 in Q2 2026.

• On a quarterly basis, Price to Book fell 359.56% year-over-year to 15.72 in Q2 2026; TTM through Jun 2026 was 15.72, a 359.56% decrease from a year earlier, with the FY2025 full-year figure at 105.56, up 9825.61% from the prior year.
• Price to Book was 15.72 for Q2 2026 at Pacific Biosciences Of California, down from 173.22 in the prior quarter.
• The five-year high for Price to Book was 173.22 in Q1 2026, with the low at 15.72 in Q2 2026.
• Average Price to Book over 5 years is 17.43, with a median of 3.06 recorded in 2023.
• The sharpest annual moves came in 2025 and 2026: Price to Book surged 9825.61% in 2025, then tumbled 359.56% in 2026.
• Over 5 years, Price to Book stood at 3.29 in 2022, then increased by 13.79% to 3.75 in 2023, then sank by 71.6% to 1.06 in 2024, then soared by 9825.61% to 105.56 in 2025, then tumbled by 114.89% to 15.72 in 2026.
• The last three Price to Book figures came in at 15.72 (Q2 2026), 173.22 (Q1 2026), and 105.56 (Q4 2025), per Business Quant data.